Serotonin transporter gene variation and refractory mesial temporal epilepsy with hippocampal sclerosis

Epilepsy Research

Volumn 85, Issue 2-3, 2009, Pages 231-234

  Kauffman, Marcelo Andrés ^a,b   Consalvo, Damián ^c   Gonzalez Morón, Dolores ^b   Aguirre, Florencia ^b   D'Alessio, Luciana ^c   Kochen, Silvia ^c  

^a Centro de Epilepsia   (Argentina)

^b Hospital Nacional Professor Dr Alejandro Posadas Servicio de Neurologia   (Argentina)

^c HOSPITAL RAMOS MEJÍA   (Argentina)

Author keywords

Gene; Hippocampal sclerosis; Pharmacogenetics; Serotonin transporter; Temporal lobe epilepsy; Treatment

Indexed keywords

ANTICONVULSIVE AGENT; SEROTONIN TRANSPORTER;

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC MARKER; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; HIPPOCAMPAL SCLEROSIS; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR EPIDEMIOLOGY; PREDICTION; PRIORITY JOURNAL; PROBABILITY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TEMPORAL LOBE EPILEPSY; TREATMENT OUTCOME;

ADULT; ALLELES; ANTICONVULSANTS; DRUG RESISTANCE; EPILEPSY, TEMPORAL LOBE; FEMALE; GENETIC VARIATION; GENOTYPE; HIPPOCAMPUS; HUMANS; INTRONS; MALE; MINISATELLITE REPEATS; RISK; SCLEROSIS; SEROTONIN PLASMA MEMBRANE TRANSPORT PROTEINS;

EID: 67650632807     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2009.03.010     Document Type: Article

References (23)

1. Albano C., Cupello A., Mainardi P., Scarrone S., and Favale E. Successful treatment of epilepsy with serotonin reuptake inhibitors: proposed mechanism. Neurochem. Res. 31 (2006) 509-514
2. Bagdy G., Kecskemeti V., Riba P., and Jakus R. Serotonin and epilepsy. J. Neurochem. 100 (2007) 857-873
3. Briellmann R.S., Mark Wellard R., Masterton R.A., Abbott D.F., Berkovic S.F., and Jackson G.D. Hippocampal sclerosis: MR prediction of seizure intractability. Epilepsia 48 (2007) 315-323
4. Cavalleri G.L., Lynch J.M., Depondt C., Burley M.W., Wood N.W., Sisodiya S.M., and Goldstein D.B. Failure to replicate previously reported genetic associations with sporadic temporal lobe epilepsy: where to from here?. Brain 128 (2005) 1832-1840
5. David S.P., Murthy N.V., Rabiner E.A., Munafo M.R., Johnstone E.C., Jacob R., Walton R.T., and Grasby P.M. A functional genetic variation of the serotonin (5-HT) transporter affects 5-HT1A receptor binding in humans. J. Neurosci. 25 (2005) 2586-2590
6. Fiskerstrand C.E., Lovejoy E.A., and Quinn J.P. An intronic polymorphic domain often associated with susceptibility to affective disorders has allele dependent differential enhancer activity in embryonic stem cells. FEBS Lett. 458 (1999) 171-174
7. Goldstein D.B., Need A.C., Singh R., and Sisodiya S.M. Potential genetic causes of heterogeneity of treatment effects. Am. J. Med. 120 (2007) S21-S25
8. Hitiris N., Mohanraj R., Norrie J., Sills G.J., and Brodie M.J. Predictors of pharmacoresistant epilepsy. Epilepsy Res. 75 (2007) 192-196
9. Hranilovic D., Stefulj J., Schwab S., Borrmann-Hassenbach M., Albus M., Jernej B., and Wildenauer D. Serotonin transporter promoter and intron 2 polymorphisms: relationship between allelic variants and gene expression. Biol. Psychiatry 55 (2004) 1090-1094
10. Manna I., Labate A., Gambardella A., Forabosco P., La Russa A., Le Piane E., Aguglia U., and Quattrone A. Serotonin transporter gene (5-Htt): association analysis with temporal lobe epilepsy. Neurosci. Lett. 421 (2007) 52-56
11. Martinez Marignac V.L., Bertoni B., Parra E.J., and Bianchi N.O. Characterization of admixture in an urban sample from Buenos Aires, Argentina, using uniparentally and biparentally inherited genetic markers. Hum. Biol. 76 (2004) 543-557
12. Merrill M.A., Clough R.W., Dailey J.W., Jobe P.C., and Browning R.A. Localization of the serotonergic terminal fields modulating seizures in the genetically epilepsy-prone rat. Epilepsy Res. 76 (2007) 93-102
13. Sander J.W. Some aspects of prognosis in the epilepsies: a review. Epilepsia 34 (1993) 1007-1016
14. Shahwan A., Murphy K., Doherty C., Cavalleri G.L., Muckian C., Dicker P., McCarthy M., Kinirons P., Goldstein D., and Delanty N. The controversial association of ABCB1 polymorphisms in refractory epilepsy: an analysis of multiple SNPs in an Irish population. Epilepsy Res. 73 (2007) 192-198
15. Siddiqui A., Kerb R., Weale M.E., Brinkmann U., Smith A., Goldstein D.B., Wood N.W., and Sisodiya S.M. Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1. N. Engl. J. Med. 348 (2003) 1442-1448
16. Szoeke C.E., Newton M., Wood J., Goldstein D., Berkovic S., OBrien T., and Sheffield L. Update on pharmacogenetics in epilepsy: a brief review. Lancet Neurol. 5 (2006) 189-196
17. Tan N.C., Heron S.E., Scheffer I.E., Pelekanos J.T., McMahon J.M., Vears D.F., Mulley J.C., and Berkovic S.F. Failure to confirm association of a polymorphism in ABCB1 with multidrug-resistant epilepsy. Neurology 63 (2004) 1090-1092
18. Tate S., and Sisodiya S. Multidrug resistance in epilepsy: a pharmacogenomic update. Expert Opin. Pharmacother. 8 (2007) 1441-1449
19. Tate S.K., Depondt C., Sisodiya S.M., Cavalleri G.L., Schorge S., Soranzo N., Thom M., Sen A., Shorvon S.D., Sander J.W., Wood N.W., and Goldstein D.B. Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoin. Proc. Natl. Acad. Sci. U.S.A. 102 (2005) 5507-5512
20. Theodore W.H., Hasler G., Giovacchini G., Kelley K., Reeves-Tyer P., Herscovitch P., and Drevets W. Reduced hippocampal 5HT1A PET receptor binding and depression in temporal lobe epilepsy. Epilepsia 48 (2007) 1526-1530
21. Wieser H.G. ILAE Commission Report. Mesial temporal lobe epilepsy with hippocampal sclerosis. Epilepsia 45 (2004) 695-714
22. Yeo A., Boyd P., Lumsden S., Saunders T., Handley A., Stubbins M., Knaggs A., Asquith S., Taylor I., Bahari B., Crocker N., Rallan R., Varsani S., Montgomery D., Alpers D.H., Dukes G.E., Purvis I., and Hicks G.A. Association between a functional polymorphism in the serotonin transporter gene and diarrhoea predominant irritable bowel syndrome in women. Gut 53 (2004) 1452-1458
23. Zimprich F., Sunder-Plassmann R., Stogmann E., Gleiss A., Dal-Bianco A., Zimprich A., Plumer S., Baumgartner C., and Mannhalter C. Association of an ABCB1 gene haplotype with pharmacoresistance in temporal lobe epilepsy. Neurology 63 (2004) 1087-1089